System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Elisabeth Bendstrup is an expert in Pulmonology at Aarhus University Hospital (Denmark). As of October 2026, ScienceLeadR ranks Elisabeth Bendstrup in the top 1% of experts worldwide for Pneumonia, Lung Diseases, Interstitial and Epidemiologic Studies. Elisabeth Bendstrup has authored 370 publications, the most recent in 2026, and is an investigator in 39 clinical trials, 13 of them ongoing. SLR score: 1,828 (community average: 125). How the SLR is computed.

LeadR Profile

Elisabeth Bendstrup Aarhus University Hospital Denmark
1 828 ScienceLeadR Reputation 1828

Unlock

Register Login
Network Map

Pulmonology

Subspecialties: Public Health - Rheumatology - Critical Care

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2011 - 2026
Source: PubMed

Aarhus University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 370

Citations

Citations: 8 811 1st author: 24 Last author: 114 Unique author: 1

Main journals

12.01 - Idiopathic interstitial pneumonias 38
Eur Clin Respir J 27
Ugeskr Laeger 20
Eur Respir J 16
Respir Res 16

Best Journals

Lancet Respir Med 6
N Engl J Med 6
Eur Respir J 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Diaphragmatic Ultrasound in Fibrosing Interstitial Lung Disease: A Systematic Review of Current Evidence.
PMID 42739189 — idiopathic pulmonary fibrosis, lung, diaphragm, lung diseases, lung diseases, interstitial		Diagnostics (Basel)20260
Transthoracic drainage of lung abscesses (TOLA): protocol for a national multicenter randomized open-label trial.
PMID 42591951 — abscess, drainage, lung, lung abscess, therapeutics, radiology, interventional		Eur Clin Respir J20260
Visibility of breathlessness in fibrotic interstitial lung disease: perceptions of international healthcare professionals.
PMID 42445234 — lung, perception, lung diseases, dyspnea, education, lung diseases, interstitial		ERJ Open Res20260
Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report.
PMID 42447235 — lung, critical care, signs and symptoms, pneumonia, research, therapeutics, lung diseases, lung diseases, interstitial		Am J Respir Crit Care Med20262
Study protocol: a 52-week, multicentre, observational, prospective study on the use of a smart platform connected to a single-inhaler triple therapy (ICS/LABA/LAMA) to evaluate effectiveness on treatment adherence and inhaler technique in patients with poorly controlled asthma.
PMID 42414967 — treatment adherence and compliance, therapeutics, asthma, lung diseases, prospective studies		BMC Pulm Med20260

Clinical Studies 39

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

N/A 21
Phase 3 8
Phase 2 7
Phase 4 2
Phase 2/Phase 3 1

By status:

Completed 16
Recruiting 8
Active not recruiting 6
Unknown 6
Enrolling by invitation 1
Not yet recruiting 1
Terminated 1

By type:

Interventional 27
Observational 12

By Monocentric/Multicentric:

monocentric 16
multicentric2to4 5
multicentric5to9 3
multicentricup10 15

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

13 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study to Evaluate the Efficacy Safety and Tolerability of BMS 986278 in Participants with Idiopathic Pulmonary Fibrosis
2023-503697-21-01 — idiopathic pulmonary fibrosis, safety, fibrosis, pulmonary fibrosis, vital capacity		Phase 3Active not recruiting2024
Senicapoc in patients with progressive fibrotic interstitial lung disease
2024-511131-97-00 — idiopathic pulmonary fibrosis, lung, fibrosis, pulmonary fibrosis, lung diseases, vital capacity, lung diseases, interstitial		Phase 2Recruiting2025
A follow up study to test long term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 1015550
2023-507353-15-00 — idiopathic pulmonary fibrosis, safety, follow-up studies, fibrosis, pulmonary fibrosis, therapeutics		Phase 3Recruiting2024
Transthoracic Drainage of Lung Abscesses A National Randomized Trial
NCT07247461 — abscess, drainage, lung, blood, piperacillin, tazobactam drug combination, lung abscess, research, records, therapeutics, hematologic tests, walk test		N/ARecruiting2026
Efficacy of a Smart add on Device in Combination With a Triple Treatment in Asthma Patients on Inhaler Technique and Adherence
NCT06908421 — treatment adherence and compliance, medication adherence, therapeutics, asthma, prospective studies		N/ARecruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS